phase II clinical study
Aleta Biotherapeutics, Cancer Research UK Partner on CAR T-Cell Engager Trial
Cancer Research UK will conduct a Phase I/II trial of ALETA-001 for lymphoma and leukemia patients who have stopped responding to anti-CD19 CAR T-cell therapy.
Clovis Oncology Begins Study of FAP-2286 Targeted Imaging Agent, Radionuclide Therapy
The Phase I/II LuMIERE study is enrolling patients with different types of tumors at the O'Neal Comprehensive Cancer Center in Alabama.
Prestige Biopharma to Begin Anti-PAUF Drug Trial for Pancreatic Cancer in France
French regulators have permitted the start of a Phase I/II clinical trial of PBP1510 in pancreatic cancer patients whose tumors overexpress PAUF.
Bristol Myers Squibb Licenses Eisai's Anti-Folate Receptor Alpha Antibody for up to $3.1B
The companies will jointly develop and commercialize Eisai's MORAb-202, which is being studied in folate receptor alpha-positive solid tumors.
AnHeart Therapeutics Begins Phase II Basket Trial of Taletrectinib in NTRK-Positive Solid Tumors
AnHeart licensed taletrectinib this month to Innovent Biologics, which will codevelop and commercialize the drug in greater China.